The Elucigene CF29 ASR reagents are for the detection of 29 cystic fibrosis mutations using ARMS technology. The Elucigene reagents have been developed specifically to meet the requirements of the “Laboratory Standards and Guidelines for Population-based Cystic Fibrosis Carrier Screening” published by the American College of Medical Genetics.
CF 29 consists of four primer mixes, dilution buffer and a gel loading dye. It is capable of detecting the core panel of 25 mutations selected by the ACMG in addition to four others. El;ucigene’s use of ARMS allele specific amplification is able to discriminate between the benign 506, 507 and 508 polymorphisms directly, eliminating the need for reflex testing. ARMS is a simple yet accurate technique that only requires a thermal cycler and gel electrophoresis equipment. Poly-T ASR reagents are available separately for determination of intron 8 Poly-T status when appropriate (i.e. R117H carriers).
Orchid Diagnostics
www.orchid.com
Keywords: ASR, molecular diagnostics
